RxDoctor Payments Data

Denise Corriveau, PA

Physician Assistant · San Diego, CANPI 1902420938

Payments from drug & device makers

$7,407in general payments, 2019–2025

Across 336 payments — averaging $22.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$668
  • Johnson & Johnson$654
  • Pfizer$570
  • Regeneron Healthcare Solutions, Inc.$542
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$7,399100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,407 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$11,340
Medicare patients
82
Services billed
82

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide52$39,649
CreonLipase/Protease/Amylase18$39,087
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates293$16,778
TrulancePlecanatide15$11,295
Budesonide EcBudesonide14$3,007
Omeprazole154$2,393
Dexlansoprazole DrDexlansoprazole13$2,387
SutabSod Sulf/Pot Chloride/Mag Sulf13$2,126
Pantoprazole Sodium172$1,927
Sucralfate45$1,234
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl68$901
Esomeprazole Magnesium16$824
Famotidine65$571
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl29$459
Dicyclomine Hcl25$375

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon$1,346$78,73670 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$1,314$11,29515 claims
Braintree Laboratories, Inc.Sutab$116$2,12613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →